Archive: 26/06/2018

When one drug fails, a new door opens for cancer treatment

A new class of cancer drugs—called CDK4/6 inhibitors—recently approved to treat breast cancer can stunt the cancer's growth and replication. It is also being explored for a number of other cancers. Unfortunately, patients ...

page 3 from 10